About goBalto
goBalto is a company based in San Francisco (United States) founded in 2008 was acquired by Oracle in October 2018. goBalto has raised $38.25 million across 7 funding rounds from investors including Qualcomm, Oracle and Mitsui Global Investment. The company has 66 employees. goBalto operates in a competitive market with competitors including Inato, NoviSci, Acme Clinical Trials, AltaVoice and Dementias Platform, among others.
- Headquarter San Francisco, United States
- Employees 66
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website gobalto.com
- Social LinkedIn X
- Acquired by Oracle (Oct 2018)
Funding Insights of goBalto
goBalto has successfully raised a total of $38.25M across 7 strategic funding rounds. The most recent funding activity was a Series C round of $12.11 million completed in January 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $38.25M
- Total Rounds 7
- Last Round Series C — $12.11M
- First Round $170,000
(Jun 2009)
- Investors Count 7
All 7 funding rounds of goBalto with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2015 | $12.11M | Series C | – | Mitsui Global Investment, Dolby Family Ventures | – |
| Feb 2014 | $4.97M | Series B | – | – | |
| Dec 2012 | $12M | Series B | – | EDBI | |
| Oct 2011 | $5M | Series A | – | Aberdare Ventures, West Health | – |
| Sep 2011 | $3.5M | Series A | – | – | – |
| Jul 2009 | $500,000 | Angel Round | – | – | – |
| Jun 2009 | $170,000 | Seed | – | – | – |
8 investors in total: 7 institutional and 1 angel.
Investors in goBalto
goBalto has secured backing from 8 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Qualcomm, Oracle and Mitsui Global Investment.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Corporate-backed venture capital firm focused on healthcare, IT, and multiple sectors | – | mitsui-global.com | Menlo Park, United States | |
Venture capital fund focused on early-stage biotech, life sciences, IT, and multiple sectors | – | dolbyventures.com | San Francisco, United States | |
Government-backed investments are directed toward healthcare, fintech, and various sectors. | – | edbi.com | Singapore, Singapore | |
US Life-Sciences sectors are targeted for investment by Aberdare Ventures. | – | aberdare.com | San Francisco, United States | |
Provider of cloud and AI-based cellular communication ICs | 1985 | qualcomm.com | San Diego, United States | |
West Health is focused on improving aging and healthcare for seniors in America. | – | westhealth.org | La Jolla, United States | |
Hybrid cloud infrastructure solutions are delivered for business management. | 1977 | oracle.com | Austin, United States | |
JC Jae Chung | - | – | unknown_9b90c7e05d6f4ff58 | - |
Investor details for goBalto
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of goBalto
4 dated milestones of goBalto across 10 years, from founding to its latest funding, stage changes and deals.
- Founded goBalto is founded.
- Funding First funding round of $170K.
- Funding Latest funding round, Series C, of $12.1M.
- Exit Acquired by Oracle.
Competitors of goBalto
goBalto operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inato, NoviSci, Acme Clinical Trials, AltaVoice and Dementias Platform, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| inato.com | 2016 | Paris, France | $35.52M | – | AI-based patient recruitment platform | |
| novisci.com | 2016 | Durham, United States | – | – | Provider of an online scientific sourcing tool for researchers and professionals | |
| aclinicaltrials.com | 2017 | San Jose, United States | – | – | Provides an online database of clinical trial studies for researchers. | |
| altavoice.com | 2004 | San Mateo, United States | – | – | Patient Insight Network (PIN) helping drug developers find better treatments for diseases | |
| dementiasplatform.uk | 2014 | Oxford, United Kingdom | – | – | Platform for dementia research, data access, and clinical trials collaboration. | |
| doctorpenguin.com | 2019 | United States | – | – | Provides an online platform with comprehensive health information for COVID-19. | |
| credevo.com | 2015 | Singapore | – | – | Offers clinical trial management, feasibility assessments, and regulatory support services. | |
| australianclinicaltrials.com | 2015 | St Kilda, Australia | – | – | Platform connecting people to clinical trials for research and health studies in Australia. |
Detailed competitors of goBalto
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of goBalto
Websites that share an audience with goBalto (gobalto.com).
- Global rank#4,134,531
among all websites
- Category rank#5,145
Health · Biotechnology and Pharmaceuticals
- Bounce rate8%
- Pages per visit7.3
- Average visit7 min 16 sec
- DevicesDesktop 82% · Mobile 18%
Websites whose visitors overlap most with goBalto. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| centerwatch.com | 100% | 158.2K | #254,725 | View details | |
| covance.com | 83% | 20.2K | #688,229 | View details | |
| iconplc.com | 76% | 476.9K | #92,950 | View details | |
| phrma.org | 74% | 63.3K | #555,565 | View details | |
| jubilantbiosys.com | 74% | 12.2K | #2,731,637 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 14 similar websites and full traffic analytics for goBalto
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 14 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Gobalto
Complete news archive for goBalto
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to goBalto
10 companies that operate in the same segment as goBalto (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about goBalto
goBalto was founded in 2008 and raised its 1st funding round 1 year after it was founded.
goBalto is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
goBalto is a funded company, having raised a total of $38.25M across 7 funding rounds to date. The company's 1st funding round was a Seed of $170K, raised on Jun 2009.
goBalto has 66 employees.
goBalto provides cloud-based electronic solutions for clinical trial design, data capture analysis. It has three products: SELECT for optimising site selection, ACTIVATE for starting and designing clinical trials and ANALYZE for analysing the electronic data captured through Activate. All its products and solutions are in compliance with 21 CFR Part 11. The company claims that it can help in reducing cycle times by over 30, to have activated 38000 sites in 70 countries and over 75 adoption by global pharma companies and CROs. The companys platform can be used for site identification, feasibility assessment and selection, site activation and also to track adherence to timelines and budget.The companys clientele includes Covance, CMIC HOLDINGS, Genentech Roche, ICON, INC Research and Novartis.
goBalto has 8 investors. Key investors include Qualcomm, Oracle, Mitsui Global Investment, Dolby Family Ventures, and EDBI.
Yes. goBalto was acquired by Oracle in October 2018.